- /
- Supported exchanges
- / US
- / COR.NYSE
Cencora Inc. (COR NYSE) stock market data APIs
Cencora Inc. Financial Data Overview
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cencora Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Cencora Inc. data using free add-ons & libraries
Get Cencora Inc. Fundamental Data
Cencora Inc. Fundamental data includes:
- Net Revenue: 337 397 M
- EBITDA: 5 717 M
- Earnings Per Share: 17
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-04
- EPS/Forecast: 4.56
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cencora Inc. News
New
Update: FTC Sues to Block Covetrus' $3.5 Billion Acquisition of Cencora's MWI Veterinary Supply
(Updated to add Covetrus' comment in paragraph four.) Cencora (COR), the parent company of MWI Ve Keep reading this article with Yahoo Finance Plus Silver Upgrade to Silver Silver Premium news Ful...
Covetrus Issues Statement on FTC Decision to Challenge Proposed Merger with MWI Animal Health
PORTLAND, Maine, Nov. 13, 2026 /PRNewswire/ -- Covetrus, a leading animal health technology, product and services company, today issued the following statement in response to the Federal Trade Commiss...
FTC sues to block $3.5B Covetrus-MWI deal (update)
[Veterinarian in scrubs petting dog in exam room] MoMo Productions UPDATE 10:45 AM: Adds FTC confirming lawsuit. The US Federal Trade Commission filed a lawsuit to block CD&R- and TPG-owned (TPG [ht...
Cencora’s Q3 CY2026 earnings call: our top 5 analyst questions
Cencora's Q3 CY2026 earnings call: our top 5 analyst questions Cencora delivered calendar Q3 2026 results that aligned with market expectations on revenue and topped analyst profit forecasts. Managem...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.